Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release

References

• Hoffman AS. The origins and evolution of “controlled” drug delivery systems. J Control Release. 2008;132:153–163.
   PubMed Web of Science ®Google Scholar
• Park K. Controlled drug delivery systems: past forward and future back. J Control Release. 2014;190:3–8.
   PubMed Web of Science ®Google Scholar
• McConnell EL, Short MD, Basit AW. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J Control Release. 2008;130:154–160.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Kumria R. Microbially triggered drug delivery to the colon. Eur J Pharm Sci. 2003;18:3–18.
   PubMed Web of Science ®Google Scholar
• Jain A, Gupta Y, Jain SK. Azo chemistry and its potential for colonic delivery. Crit Rev Ther Drug Carr Syst. 2006;23:349–399.
   PubMed Web of Science ®Google Scholar
• Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015;16:731–741.
   PubMed Web of Science ®Google Scholar
• Linskens RK, Huijsdens XW, Savelkoul PH, et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Gastroenterology. 2001;234(Suppl.):29–40.
   Google Scholar
• Karrout Y, Neut C, Wils D, et al. Colon targeting with bacteria-sensitive films adapted to the disease state. Eur J Pharm Biopharm. 2009;73:74–81.
   PubMed Web of Science ®Google Scholar
• Smart Global Health. [ cited 2016 Jan]. Available from: http://www.smartglobalhealth.org/issues/entry/infectious-diseases
   Google Scholar
• Proctor RA, Von Eiff C, Kahl BC, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol. 2006;4:295–305.
   PubMed Web of Science ®Google Scholar
• Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005;3:948–958.
   PubMed Web of Science ®Google Scholar
• Xiong M-H, Li Y-J, Bao Y, et al. Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery. Adv Mater. 2012;24:6175–6180.
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–193.
   PubMed Web of Science ®Google Scholar
• Bridier A, Briandet R, Thomas V, et al. Resistance of bacterial biofilms to disinfectants: a review. Biofouling. 2011;27:1017–1032.
   PubMed Web of Science ®Google Scholar
• Aiassa V, Barnes AI, Albesa I. Resistance to ciprofloxacin by enhancement of antioxidant defenses in biofilm and planktonic Proteus mirabilis. Biochem Biophys Res Comm. 2010;393:84–88.
   PubMed Web of Science ®Google Scholar
• Mack WN, Mack JP, Ackerson AO. Microbial film development in a trickling filter. Microbial Ecol. 1975;2:215–226.
   PubMed Web of Science ®Google Scholar
• Hoiby N. Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies. J Cystic Fibrosis. 2002;1:249–254.
   PubMedGoogle Scholar
• Maddi A, Scannapieco FA. Oral biofilms, oral and periodontal infections, and systemic disease. Am J Dent. 2013;26:249–254.
   PubMed Web of Science ®Google Scholar
• Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31:81–110.
   Web of Science ®Google Scholar
• Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hospt Infect. 2001;49:87–93.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2011. Report on the burden of endemic health care-associated infection worldwide; [ cited 2016 Jan. Available from: http://apps.who.int/iris/bitstream/10665/80135/1/9789241501507_eng.pdf
   Google Scholar
• Campoccia D, Montanaro L, Arciola CR A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials. 2013;34:8533–8554.
   PubMed Web of Science ®Google Scholar
• Jones GL, Russell AD, Caliskan Z, et al. A strategy for the control of catheter blockage by crystalline biofilm using the antibacterial agent triclosan. Eur Urology. 2005;48:838–845.
   PubMed Web of Science ®Google Scholar
• Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials. 2006;27:2450–2467.
   PubMed Web of Science ®Google Scholar
• González-Chomón C, Concheiro A, Alvarez-Lorenzo C. Drug-eluting intraocular lenses. Materials. 2011;4:1927–1940.
   Web of Science ®Google Scholar
• Wenke JC, Guelcher SA. Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures. Expert Opin Drug Deliv. 2011;8:1555–1569.
   PubMed Web of Science ®Google Scholar
• Chen WL, Habraken TCJ, Hennink WE, et al. Polymer-free drug-eluting stents: an overview of coating strategies and comparison with polymer-coated drug-eluting stents. Bioconjugate Chem. 2015;26:1277–1288.
   PubMed Web of Science ®Google Scholar
• McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res. 2004;427:101–106.
   PubMed Web of Science ®Google Scholar
• Alvarez-Lorenzo C, Concheiro A. Drug/medical device combination products with stimuli-responsive eluting surface. In: Alvarez-Lorenzo C, Concheiro A, editor. Smart materials for drug delivery. Vol. 2. Cambridge: Royal Society of Chemistry; 2013. p. 313–348.
   Google Scholar
• Sjollema J, Dijkstra RJ, Abeln C, et al. On-demand antimicrobial release from a temperature-sensitive polymer - comparison with ad libitum release from central venous catheters. J Control Release. 2014;188:61–66.
   PubMed Web of Science ®Google Scholar
• Komnatnyy VV, Chiang WC, Tolker-Nielsen T, et al. Bacteria-triggered release of antimicrobial agents. Angew Chem Int Ed. 2014;53:439–441.
   PubMed Web of Science ®Google Scholar
• Sawyer RG, Spengler MD, Adams R, et al. The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. Ann Surg. 1991;3:253–260.
   Web of Science ®Google Scholar
• Pornpattananangkul D, Zhang L, Olson S, et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc. 2011;133:4132–4139.
   PubMed Web of Science ®Google Scholar
• Xiong MH, Bao Y, Yang XZ, et al. Lipase-sensitive polymeric triple-layered nanogel for “on-demand” drug delivery. J Am Chem Soc. 2012;134:4355–4362.
   PubMed Web of Science ®Google Scholar
• Radovic-Moreno AF, Lu TK, Puscasu VA, et al. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano. 2012;6:4279–4287.
   PubMed Web of Science ®Google Scholar
• Si Y, Grazon C, Clavier G, et al. Rapid and accurate detection of Escherichia coli growth by fluorescent pH-sensitive organic nanoparticles for high-throughput screening applications. Biosens Bioelectron. 2016;75:320–327.
   PubMed Web of Science ®Google Scholar
• Kelly C, Jefferies C, Cryan S-A Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv. 2011;2011:1–11. ID 727241.
   Google Scholar
• Irache JM, Salman HH, Gamazo C, et al. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv. 2008;5:703–724.
   PubMed Web of Science ®Google Scholar
• Pinto-Alphandary H, Andremont A, Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents. 2000;13:155–168.
   PubMed Web of Science ®Google Scholar
• Abed N, Said-Hassane F, Zouhiri F, et al. An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance. Sci Rep. 2015;5:13500.
   PubMed Web of Science ®Google Scholar
• Xiong M-H, Bao Y, Du X-J, et al. Differential anticancer drug delivery with a nanogel sensitive to bacteria-accumulated tumor artificial environment. ACS Nano. 2013;7:10636–10645.
   PubMed Web of Science ®Google Scholar
• Lin D, Qin T, Wang Y, et al. Graphene oxide wrapped SERS tags: multifunctional platforms toward optical labeling, photothermal ablation of bacteria, and the monitoring of killing effect. ACS Appl Mater Interfaces. 2014;6:1320–1329.
   PubMed Web of Science ®Google Scholar
• Forier K, Raemdonck K, De Smedt SC, et al. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release. 2014;190:607–623.
   PubMed Web of Science ®Google Scholar
• Chen F, Liu X-M, Rice KC, et al. Tooth-binding micelles for dental caries prevention. Antimicrob Agents Chemother. 2009;53:4898–4902.
   PubMed Web of Science ®Google Scholar
• Chen F, Rice KC, Liu XM, et al. Triclosan-loaded tooth-binding micelles for prevention and treatment of dental biofilm. Pharm Res. 2010;27:2356–2364.
   PubMed Web of Science ®Google Scholar
• Chen F, Jia Z, Rice KC, et al. The development of dentotropic micelles with biodegradable tooth-binding moieties. Pharm Res. 2013;30:2808–2817.
   PubMed Web of Science ®Google Scholar
• Mogen AB, Chen F, Ahn SJ, et al. Pluronics-formulated farnesol promotes efficient killing and demonstrates novel interactions with Streptococcus mutans biofilms. Plos One. 2015;10:e0133886.
   Google Scholar
• Horev B, Klein MI, Hwang G, et al. pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. ACS Nano. 2015;9:2390–2404.
   PubMed Web of Science ®Google Scholar
• Tang X, Dai J, Xie J, et al. Enhanced antifungal activity by Ab-modified amphotericin B-loaded nanoparticles using a pH-responsive block copolymer. Nanoscale Res Lett. 2015;10:256.
   Web of Science ®Google Scholar
• Boateng JS, Matthews KH, Stevens HN, et al. Wound healing dressings and drug delivery systems, a review. J Pharm Sci. 2008;7:2892–2923.
   Web of Science ®Google Scholar
• Zahedi P, Rezaeian I, Ranaei-Siadat SO, et al. A review on wound dressings with an emphasis on electrospun nanofibrous polymeric bandages. Polym Adv Technol. 2010;21:77–95.
   Web of Science ®Google Scholar
• Thakur RA, Florek CA, Kohn J, et al. Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. Int J Pharm. 2008;364:87–93.
   PubMed Web of Science ®Google Scholar
• Liu X, Lin T, Fang J, et al. In vivo wound healing and antibacterial performances of electrospun nanofibre membranes. J Biomed Mater Res Part A. 2010;94A:499–508.
   Web of Science ®Google Scholar
• Cai Q, Bei J, Luo A, et al. Biodegradation behaviour of poly(lactide-co-glycolide) induced by microorganisms. Polym Degrad Stabil. 2001;71:243–251.
   Web of Science ®Google Scholar
• Said SS, Aloufy AK, El-Halfawy OM, et al. Antimicrobial PLGA ultrafine fibers:iInteraction with wound bacteria. Eur J Pharm Biopharm. 2011;79:108–118.
   PubMed Web of Science ®Google Scholar
• Said SS, El-Halfawy OM, El-Gowelli HM, et al. Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing. Eur J Pharm Biopharm. 2012;80:85–94.
   PubMed Web of Science ®Google Scholar
• Pavlukhina S, Zhuk I, Mentbayeva A, et al. Small-molecule-hosting nanocomposite films with multiple bacteria-triggered responses. NPG Asia Mater. 2014;6:e121.
   Web of Science ®Google Scholar
• Zhuk I, Jariwala F, Attygalle AB, et al. Self-defensive layer-by-layer films with bacteria-triggered antibiotic release. ACS Nano. 2014;8:7733–7745.
   PubMed Web of Science ®Google Scholar
• Handke LD, Rogers KL, Olson ME, et al. Staphylococcus epidermidis saeR is an effector of anaerobic growth and a mediator of acute inflammation. Infect Immun. 2008;76:141–152.
   PubMed Web of Science ®Google Scholar
• Andersen KB, Von Meyenburg K. Are growth rates of Escherichia coli in batch cultures limited by respiration? J Bacteriol. 1980;144:114–123.
   PubMed Web of Science ®Google Scholar
• Lu Y, Wu Y, Liang J, et al. Self-defensive antibacterial layer-by-layer hydrogel coatings with pH-triggered hydrophobicity. Biomaterials. 2015;45:64–71.
   PubMed Web of Science ®Google Scholar
• McCann MT, Gilmore BF, Gorman SP. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J Pharm Pharmacol. 2008;60:1551–1571.
   PubMed Web of Science ®Google Scholar
• Yeh PJ, Hegreness MJ, Aiden AP, et al. Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol. 2009;7:460–466.
   PubMed Web of Science ®Google Scholar
• Dorsthorst DTAT, Verweij PE, Meis JFGM, et al. Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates. Antimicrob Agents Chemother. 2005;49:3341–3346.
   PubMed Web of Science ®Google Scholar
• Hasan J, Crawford RJ, Ivanova EP. Antibacterial surfaces: the quest for a new generation of biomaterials. Trends Biotechnol. 2013;31:295–304.
   PubMed Web of Science ®Google Scholar
• Zhao J, Millians W, Tang SD, et al. Self-stratified antimicrobial acrylic coatings via one-step UV curing. ACS Appl Mater Interfaces. 2015;7:18467–18472.
   PubMed Web of Science ®Google Scholar
• Traba C, Liang JF. Bacteria responsive antibacterial surfaces for indwelling device infections. J Control Release. 2015;198:18–25.
   PubMed Web of Science ®Google Scholar
• Tu Z, Volk M, Shah K, et al. Constructing bioactive peptides with pH-dependent activities. Peptides. 2009;30:1523–1528.
   PubMed Web of Science ®Google Scholar
• Nzakizwanayo J, Hanin A, Alves DR, et al. Bacteriophage can prevent encrustation and blockage of urinary catheters by Proteus mirabilis. Antimicrob Agents Chemother. 2016;60:1530–1536.
   Web of Science ®Google Scholar
• Hathaway H, Alves DR, Bean J, et al. Poly(N-isopropylacrylamide-co-allylamine) (PNIPAM-co-ALA) nanospheres for the thermally triggered release of Bacteriophage K. Eur J Pharm Biopharm. 2015;96:437–441.
   PubMed Web of Science ®Google Scholar
• Newman GR, Walker M, Hobot JA, et al. Visualisation of bacterial sequestration and bactericidal activity within hydrating Hydrofiber® wound dressings. Biomaterials. 2006;27:1129–1139.
   PubMed Web of Science ®Google Scholar
• Luna-Straffon MA, Contreras-García A, Brackman G, et al. Wound debridement and antibiofilm properties of gamma-ray DMAEMA-grafted onto cotton gauzes. Cellulose. 2014;21:3767–3779.
   Web of Science ®Google Scholar
• Xue Y, Xiao H, Zhang Y. Antimicrobial polymeric materials with quaternary ammonium and phosphonium salts. Int J Mol Sci. 2015;16:3626–3655.
   PubMed Web of Science ®Google Scholar
• Huang CJ, Chen YS, Chang Y. Counterion-activated nanoactuator: reversibly switchable killing/releasing bacteria on polycation brushes. ACS Appl Mater Interfaces. 2015;7:2415−23.
   PubMed Web of Science ®Google Scholar
• Ungureanu C, Dumitriu C, Popescu S, et al. Enhancing antimicrobial activity of TiO2/Ti by torularhodin bioinspired surface modification. Bioelectrochemistry. 2016;107:14–24.
   PubMed Web of Science ®Google Scholar
• Junter GA, Thébault P, Lebrun L. Polysaccharide-based antibiofilm surfaces. Acta Biomater. 2016;30:13–25.
   PubMed Web of Science ®Google Scholar
• Mak WC, Cheung KY, Orban J, et al. Surface-engineered contact lens as an advanced theranostic platform for modulation and detection of viral infection. ACS Appl Mater Interfaces. 2015;7:25487−94.
   PubMed Web of Science ®Google Scholar
• Pavlukhina SV, Kaplan JB, Xu L, et al. Noneluting enzymatic antibiofilm coatings. ACS Appl Mater Interfaces. 2012;4:4708–4716.
   PubMed Web of Science ®Google Scholar
• Laloyaux X, Fautre E, Blin T, et al. Temperature-responsive polymer brushes switching from bactericidal to cell-repellent. Adv Mater. 2010;22:5024–5028.
   PubMed Web of Science ®Google Scholar
• Ilčíková M, Tkáč J, Kasák P Switchable materials containing polyzwitterion moieties. Polymers. 2015;7:2344–2370.
   Web of Science ®Google Scholar
• Cheng G, Xue H, Zhang Z, et al. A switchable biocompatible polymer surface with self-sterilizing and nonfouling capabilities. Angew Chem Int Ed. 2008;47:8831–8834.
   PubMed Web of Science ®Google Scholar
• Mi L, Jiang S. Synchronizing nonfouling and antimicrobial properties in a zwitterionic hydrogel. Biomaterials. 2012;33:8928–8933.
   PubMed Web of Science ®Google Scholar
• Cao ZQ, Mi L, Mendiola J, et al. Reversibly switching the function of a surface between attacking and defending against bacteria. Angew Chem Int Ed. 2012;51:2602–2605.
   PubMed Web of Science ®Google Scholar
• Welscher YMT, Napel HHT, Balagué MM, et al. Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. J Biol Chem. 2008;293:6393–6401.
   Web of Science ®Google Scholar
• Gray KC, Palacios DS, Dailey I, et al. Amphotericin primarily kills yeast by simply binding ergosterol. P Natl Acad Sci USA. 2012;109:2234–2239.
   PubMed Web of Science ®Google Scholar
• Segura T, Puga AM, Burillo G, et al. Materials with fungi-bioinspired surface for efficient binding and fungi-sensitive release of antifungal agents. Biomacromolecules. 2014;15:1860–1870.
   PubMed Web of Science ®Google Scholar
• Alvarez-Lorenzo C, Bucio E, Burillo G, et al. Medical devices modified at the surface by gamma-ray grafting for drug loading and delivery. Expert Opin Drug Deliv. 2010;7:173–185.
   PubMed Web of Science ®Google Scholar
• Glinel K, Thebault P, Humblot V, et al. Antibacterial surfaces developed from bio-inspired approaches. Acta Biomater. 2012;8:1670–1684.
   PubMed Web of Science ®Google Scholar
• Nadell CD, Xavier JB, Levin SA, et al. The evolution of quorum sensing in bacterial biofilms. Plos Biol. 2008;6:171–199.
   Web of Science ®Google Scholar
• Ramli NSK, Guan CE, Nathan S, et al. The effect of environmental conditions on biofilm formation of Burkholderia pseudomallei clinical isolates. PLoS ONE. 2012;7:e44104.
   Google Scholar
• Jones SM, Dang TT, Martinuzzi R. Use of quorum sensing antagonists to deter the formation of crystalline Proteus mirabilis biofilms. Int J Antimicrob Agents. 2009;34:360–364.
   PubMed Web of Science ®Google Scholar
• Lazar V. Quorum sensing in biofilms – how to destroy the bacterial citadels or their cohesion/power? Anaerobe. 2011;17:280–285.
   PubMed Web of Science ®Google Scholar
• Manefield M, De Nys R, Kumar N, et al. Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein. Microbiology. 1999;145:283–291.
   PubMed Web of Science ®Google Scholar
• Hume EBH, Baveja J, Muirf B, et al. The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials. 2004;25:5023–5030.
   PubMed Web of Science ®Google Scholar
• Al-Bataineh SA, Luginbuehl R, Textor M, et al. Covalent immobilization of antibacterial furanones via photochemical activation of perfluorophenylazide. Langmuir. 2009;25:7432–7437.
   PubMed Web of Science ®Google Scholar
• Piletska E, Stavroulakis G, Larcombe LD, et al. Passive control of quorum sensing: prevention of Pseudomonas aeruginosa biofilm formation by imprinted polymers. Biomacromolecules. 2011;12:1067–1071.
   PubMed Web of Science ®Google Scholar
• Brackman G, Garcia-Fernandez MJ, Lenoir J, et al. Dressings loaded with cyclodextrin-hamamelitannin complexes increase staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communities. Macromol Biosci. Forthcoming 2016. doi:10.1002/mabi.201500437.
   PubMedGoogle Scholar
• Concheiro A, Alvarez-Lorenzo C. Chemically cross-linked and grafted cyclodextrin hydrogels: from nanostructures to drug-eluting medical devices. Adv Drug Deliv Rev. 2013;65:1188–1203.
   PubMed Web of Science ®Google Scholar